Eplontersen approved to treat adults with rare inherited nerve disease or polyneuropathy
Friday, 4 April 2025 11:43
SMMT: Best month ever for new EV registrations but market share misses mandated target
Friday, 4 April 2025 09:34
CMA believes remedies offer in Safran / Collins may address competition concerns
Friday, 4 April 2025 07:31